Tren Dosage & Drug Information

Indications/Uses

Haemorrhage or threatened haemorrhage associated w/ excessive fibrinolysis. Management of haemophiliacs undergoing dental extractions, prophylaxis of hereditary angioedema.

Dosage/Direction for Use

Adult Cap 4-6 cap daily in 2-3 divided doses. Inj 0.5-1 g tds by slow IV inj.

Administration

May be taken with or without food.

Contraindications

History or risk of thrombosis, acquired disturbances of colour vision.

Special Precautions

Haematuria caused by renal parenchymal disease, thrombotic states. Renal impairment. Lactation.

Adverse Reactions

Anorexia, hypnosia, pruritus, erythema, rash, GI disturbances, disturbances in colour vision (discontinue).

View ADR Reporting Link

Drug Interactions

Concomitant use w/ OCs, oestrogens, factor IX complex.

MIMS Class

Haemostatics

ATC Classification

B02AA02 - tranexamic acid ; Belongs to the class of amino acid antifibrinolytics. Used in the treatment of hemorrhage.

Regulatory Classification

B

Presentation/Packing

Form

Tren cap 250 mg

Packing/Price

50 × 10's

Form

Tren inj 100 mg/mL

Packing/Price

5 mL x 50 × 1's

Tren

tranexamic acid

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries